Digital companions for oncology therapeutics
Alacrity Care’s CloudOnc® platform enables the next generation of precision technologies for toxicity prediction and personalized management.
We develop end-to-end solutions that address key AE management needs
Our digital biomarkers are unlocking the real-world potential of AI through best-in-class real world data collection and a robust infrastructure of clinical support.
Solution
Integrated data collection in the patient’s home
We leverage a broad spectrum of wearables, spot assessment tools, and point-of-care blood analysis devices to design a monitoring approach focused on specific AE detection needs.
Applying the potential of AI in real-world clinical models
Our analytics enable the detection of SAEs 6-12 hours ahead of the current treatment paradigm, and detection of low-grade AEs >24hrs ahead of the current treatment paradigm. Our oncology digital biomarker enables the majority of AEs to be detected and managed through fully digital workflows.
Our infrastructure difference
Clinical support
The 24/7 monitoring backend of licensed oncology practitioners enables acute event escalation and seamless integration into a multitude of clinical settings.
Patient services
Patient navigators remotely onboard and support patients 1:1 through the treatment journey. Our service approach creates unparalleled patient compliance.